Drug Profile
Apomorphine transdermal patch - Altea
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Altea Therapeutics
- Class Analgesics; Antiparkinsonians; Aporphines; Erectile dysfunction therapies; Quinolines; Small molecules
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease